← All organizations

Beijing Immunochina Medical Science & Technology Co., Ltd.

For profitWebsite ↗

Also known as: Beijing Immunochina Medical Science & Technology Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 31, 2025

Timeline

2010s

Apr 1, 2015
Beijing Immunochina Medical Science & Technology Co., Ltd.— Founded

Drugs by trial phase (21 distinct, 27 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (15 own, 0 via acquisition)

Indications

Studied for

Recent trials (27)

NCT06886919Lead sponsorEarly Phase 1Mar 31, 2025
NCT06852573Lead sponsorPhase 1Feb 20, 2025
NCT06718738Lead sponsorPhase 1Dec 15, 2024
NCT06690359Lead sponsorEarly Phase 1Dec 13, 2024
NCT06691308Lead sponsorEarly Phase 1Nov 12, 2024
NCT06412458Lead sponsorPhase 1Jun 15, 2024
NCT06209671Lead sponsorPhase 1Jan 15, 2024
NCT05480501Lead sponsorEarly Phase 1Jul 11, 2022
NCT05309213Lead sponsorPhase 1/Phase 2Apr 1, 2022
NCT05287165Lead sponsorEarly Phase 1Mar 10, 2022
NCT05275062Lead sponsorEarly Phase 1Feb 15, 2022
NCT05117138Lead sponsorPhase 1/Phase 2Jan 1, 2022
NCT05155215Lead sponsorPhase 1/Phase 2Dec 31, 2021
NCT05123209Lead sponsorPhase 1Aug 24, 2021
NCT05478343Lead sponsorEarly Phase 1May 6, 2021

Details

Founded: Beijing, CN Apr 1, 2015
Last known activity: Mar 31, 2025